points more than the MSCI All-Country World Index. Nearly half of the fund's exposure is in top holding Nektar Therapeutics NKTR , a domestic small-cap firm. Big sector bets and a preference for smaller-cap firms are nothing new for
Technosphere insulin has consistently shown signs that it not only improves upon its struggling predecessor ( Pfizer PFE and Nektar's NKTR Exubera), but also that it has the potential to provide better control of glucose levels than the most advanced forms of injectable
(Reuters) - Nektar Therapeutics said its experimental drug to treat chronic pain in patients with arthritis of the knee failed to meet its main goal in a mid-stage clinical trial.
We are dropping coverage of Nektar Therapeutics NKTR to focus our resources elsewhere.
Nektar Therapeutics NKTR reported another quarter of year-over-year revenue decline because of the marketing failure of its inhaled insulin product
estimate in place after reviewing Nektar Therapeutics ' NKTR fourth-quarter results. Total ..... results from a Phase II study of NKTR -118 in patients with opioid ..... Management has indicated that NKTR -118 will be partnered with another
Nektar Therapeutics NKTR announced today that Novartis NVS will ..... programs, including Amikacin Inhale ( NKTR -061), Ciprofloxacin inhaled powder, and inhaled vancomycin ( NKTR -063). While Nektar wasn't in dire
After reviewing Nektar's NKTR second-quarter earnings, we are maintaining our fair value estimate. Second-quarter revenue dropped to $40 million from
Nektar Therapeutics NKTR has been making strides to move past its Exubera failure, and ..... approval, and two of Nektar's proprietary drug candidates-- NKTR -118 and NKTR -102--have recently produced strong results in Phase I studies
Nektar Therapeutics NKTR announced Wednesday that an increased risk of lung cancer was associated with its inhaled insulin when compared with the control